{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:06:56Z","timestamp":1782940016233,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Copenhagen University Hospital, Rigshospitalet","award":["R167-A7352-B3897"],"award-info":[{"award-number":["R167-A7352-B3897"]}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"crossref","award":["8113-00009B"],"award-info":[{"award-number":["8113-00009B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["8113-00009B"],"award-info":[{"award-number":["8113-00009B"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004785","name":"NordForsk","doi-asserted-by":"publisher","award":["8114-00005B"],"award-info":[{"award-number":["8114-00005B"]}],"id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","award":["305340"],"award-info":[{"award-number":["305340"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Necrotizing soft-tissue infection (NSTI) is a severe and\u00a0fast-progressing bacterial infection. Prognostic biomarkers may provide valuable information in treatment guidance and decision-making, but none have provided sufficient robustness to have a clinical impact. YKL-40 may reflect the ongoing pathological inflammatory processes more accurately than traditional biomarkers as it is secreted by the activated immune cells, but its prognostic yields in NSTI remains unknown. For this purpose, we investigated the association between plasma YKL-40 and 30-day mortality in patients with NSTI, and assessed its value as a marker of disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We determined plasma YKL-40 levels in patients with NSTI (n\u2009=\u2009161) and age-sex matched controls (n\u2009=\u200965) upon admission and at day 1, 2 and 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Baseline plasma YKL-40 was 1191\u00a0ng\/mL in patients with NSTI compared with 40\u00a0ng\/mL in controls (p\u2009&lt;\u20090.001). YKL-40 was found to be significantly higher in patients with septic shock (1942 vs. 720\u00a0ng\/mL, p\u2009&lt;\u20090.001), and in patients receiving renal-replacement therapy (2382 vs. 1041\u00a0ng\/mL, p\u2009&lt;\u20090.001). YKL-40 correlated with Simplified Acute Physiology Score II (Rho 0.33, p\u2009&lt;\u20090.001). Baseline YKL-40 above 1840\u00a0ng\/mL was associated with increased risk of 30-day mortality in age-sex-comorbidity adjusted analysis (OR 3.77, 95% CI; 1.59\u20139.24, p\u2009=\u20090.003), but after further adjustment for Simplified Acute Physiology Score II no association was found between YKL-40 and early mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>High plasma YKL-40 to be associated with disease severity, renal-replacement therapy and risk of death in patients with NSTI. However, YKL-40 is not an independent predictor of 30-day mortality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06760-x","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:10:49Z","timestamp":1633896649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-8041","authenticated-orcid":false,"given":"Morten","family":"Hedetoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Bo","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-2262","authenticated-orcid":false,"given":"Martin Bruun","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Sidenius","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1147-379X","authenticated-orcid":false,"given":"Ole","family":"Hyldegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"6760_CR1","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","volume":"377","author":"DL Stevens","year":"2017","unstructured":"Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253\u201365.","journal-title":"N Engl J Med"},{"key":"6760_CR2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041302","volume":"10","author":"M Hedetoft","year":"2020","unstructured":"Hedetoft M, Madsen M, Madsen L, Hyldegaard O. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005\u20132018: a Danish nationwide register-based cohort study. BMJ Open. 2020;10: e041302.","journal-title":"BMJ Open"},{"key":"6760_CR3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s10096-016-2704-y","volume":"35","author":"U Naseer","year":"2016","unstructured":"Naseer U, Steinbakk M, Blystad H, Caugant DA. Epidemiology of invasive group A streptococcal infections in Norway 2010\u20132014: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2016;35:1639\u201348.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6760_CR4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/bjd.15615","volume":"177","author":"E Audureau","year":"2017","unstructured":"Audureau E, Hua C, de Prost N, Hemery F, Decousser JW, Bosc R, et al. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Br J Dermatol. 2017;177:1575\u201382.","journal-title":"Br J Dermatol"},{"key":"6760_CR5","first-page":"449","volume":"35","author":"AM Soltani","year":"2014","unstructured":"Soltani AM, Best MJ, Francis CS, Allan BJ, Askari M, Panthaki ZJ. Trends in the incidence and treatment of necrotizing soft tissue infections: an analysis of the national hospital discharge survey. J Burn Care Res. 2014;35:449\u201354.","journal-title":"J Burn Care Res"},{"key":"6760_CR6","first-page":"195","volume":"8","author":"P Khamnuan","year":"2015","unstructured":"Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Tantraworasin A. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med. 2015;8:195\u2013202.","journal-title":"Int J Gen Med"},{"key":"6760_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","volume":"26","author":"M Peetermans","year":"2020","unstructured":"Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26:8\u201317. https:\/\/doi.org\/10.1016\/j.cmi.2019.06.031.","journal-title":"Clin Microbiol Infect"},{"key":"6760_CR8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00134-019-05730-x","volume":"45","author":"MB Madsen","year":"2019","unstructured":"Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, Bruun T, et al. Patient\u2019 s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med. 2019;45:1241\u201351.","journal-title":"Intensive Care Med"},{"key":"6760_CR9","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1002\/bjs.9371","volume":"101","author":"T Goh","year":"2014","unstructured":"Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119\u201325.","journal-title":"Br J Surg"},{"key":"6760_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06071-w","author":"T Urbina","year":"2020","unstructured":"Urbina T, Madsen MB, de Prost N. Understanding necrotizing soft tissue infections in the intensive care unit. Intensive Care Med. 2020. https:\/\/doi.org\/10.1007\/s00134-020-06071-w.","journal-title":"Intensive Care Med"},{"key":"6760_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-030-57616-5_11","volume-title":"Necrotizing soft tissue infections","author":"E Saccenti","year":"2020","unstructured":"Saccenti E, Svensson M. Systems biology and biomarkers in necrotizing soft tissue infections. In: Necrotizing soft tissue infections. Cham: Springer; 2020. p. 167\u201386."},{"key":"6760_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/SLA.0000000000002774","volume":"269","author":"SM Fernando","year":"2019","unstructured":"Fernando SM, Tran A, Cheng W, Rochwerg B, Kyeremanteng K, Seely AJE, et al. Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis. Ann Surg. 2019;269:58\u201365.","journal-title":"Ann Surg"},{"key":"6760_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/rg.282075048","volume":"28","author":"RB Levenson","year":"2008","unstructured":"Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008;28:519\u201328.","journal-title":"Radiographics"},{"key":"6760_CR14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00134-015-3830-1","volume":"41","author":"H Nougue","year":"2015","unstructured":"Nougue H, Le Maho A-L, Boudiaf M, Blancal J-P, Gayat E, Le Dorze M, et al. Clinical and imaging factors associated with severe complications of cervical necrotizing fasciitis. Intensive Care Med. 2015;41:1256\u201363.","journal-title":"Intensive Care Med"},{"key":"6760_CR15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/000313481307901030","volume":"79","author":"S Schwartz","year":"2013","unstructured":"Schwartz S, Kightlinger E, de Virgilio C, de Virgilio M, Kaji A, Neville A, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Am Surg. 2013;79:1102\u20135.","journal-title":"Am Surg"},{"key":"6760_CR16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archsurg.142.9.840","volume":"142","author":"A Yaghoubian","year":"2007","unstructured":"Yaghoubian A, de Virgilio C, Dauphine C, Lewis RJ, Lin M. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg. 2007;142:840\u20136.","journal-title":"Arch Surg"},{"key":"6760_CR17","first-page":"1","volume":"2019","author":"P Polzik","year":"2018","unstructured":"Polzik P, Gr\u00f8ndal O, Tavenier J, Madsen MB, Anderson O, Hedetoft M, et al. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study. Sci Rep. 2018;2019:1\u20138.","journal-title":"Sci Rep"},{"key":"6760_CR18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","volume":"20","author":"MB Hansen","year":"2016","unstructured":"Hansen MB, Rasmussen LS, Garred P, Bidstrup D, Madsen MB, Hyldegaard O. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Crit Care. 2016;20:40.","journal-title":"Crit Care"},{"key":"6760_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000447327","volume":"8","author":"MB Hansen","year":"2016","unstructured":"Hansen MB, Rasmussen LS, Pilely K, Hellemann D, Hein E, Madsen MB, et al. The lectin complement pathway in patients with necrotizing soft tissue infection. J Innate Immun. 2016;8:507\u201316.","journal-title":"J Innate Immun"},{"key":"6760_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep42179","author":"MB Hansen","year":"2017","unstructured":"Hansen MB, Rasmussen LS, Svensson M, Chakrakodi B, Bruun T, Madsen MB, et al. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/srep42179.","journal-title":"Sci Rep"},{"key":"6760_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00303-7","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:1\u201320. https:\/\/doi.org\/10.1038\/s41392-020-00303-7.","journal-title":"Signal Transduct Target Ther"},{"key":"6760_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/SHK.0b013e31819e2c0c","volume":"32","author":"N Hattori","year":"2009","unstructured":"Hattori N, Oda S, Sadahiro T, Nakamura M, Abe R, Shinozaki K, et al. YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock. 2009;32:393\u2013400.","journal-title":"Shock"},{"key":"6760_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.imbio.2013.04.010","volume":"218","author":"B Kornblit","year":"2013","unstructured":"Kornblit B, Hellemann D, Munthe-Fog L, Bonde J, Str\u00f8m JJ, Madsen HO, et al. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis\u2014experience from two prospective cohorts. Immunobiology. 2013;218:1227\u201334. https:\/\/doi.org\/10.1016\/j.imbio.2013.04.010.","journal-title":"Immunobiology"},{"key":"6760_CR24","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.4238\/2015.May.25.21","volume":"14","author":"JP Liu","year":"2015","unstructured":"Liu JP, Wang XW, Qie LP. Disease indicators for sepsis and analysis of sepsis treatment in children using the continuous blood purification technique. Genet Mol Res. 2015;14:5685\u201393.","journal-title":"Genet Mol Res"},{"key":"6760_CR25","volume":"5","author":"MB Hansen","year":"2015","unstructured":"Hansen MB, Simonsen U, Garred P, Hyldegaard O. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study. BMJ Open. 2015;5: e006995.","journal-title":"BMJ Open"},{"key":"6760_CR26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Elm","year":"2007","unstructured":"Elm E, Altman D, Egger M, Stuart J, G\u00f8tzsche P, Vandenbroucke J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137.","journal-title":"Lancet"},{"key":"6760_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/aas.13024","volume":"62","author":"MB Madsen","year":"2018","unstructured":"Madsen MB, Skrede S, Bruun T, Arnell P, Rosen A, Nekludov M, et al. Necrotizing soft tissue infections\u2014a multicentre, prospective observational study (INFECT): protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2018;62:272\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"key":"6760_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","volume":"412","author":"SE Bojesen","year":"2011","unstructured":"Bojesen SE, Johansen JS, Nordestgaard BG. Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta. 2011;412:709\u201312.","journal-title":"Clin Chim Acta"},{"key":"6760_CR29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47:458\u201372.","journal-title":"Biom J"},{"key":"6760_CR30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.burns.2011.07.008","volume":"38","author":"NP Bernal","year":"2012","unstructured":"Bernal NP, Latenser BA, Born JM, Liao J. Trends in 393 necrotizing acute soft tissue infection patients 2000\u20132008. Burns. 2012;38:252\u201360.","journal-title":"Burns"},{"key":"6760_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/sur.2007.053","volume":"9","author":"OL Gunter","year":"2008","unstructured":"Gunter OL, Guillamondegui OD, May AK, Diaz JJ. Outcome of necrotizing skin and soft tissue infections. Surg Infect (Larchmt). 2008;9:443\u201350.","journal-title":"Surg Infect (Larchmt)"},{"key":"6760_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13017-016-0097-y","volume":"11","author":"G Jabbour","year":"2016","unstructured":"Jabbour G, El-Menyar A, Peralta R, Shaikh N, Abdelrahman H, Mudali IN, et al. Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital. World J Emerg Surg. 2016;11:1\u201310. https:\/\/doi.org\/10.1186\/s13017-016-0097-y.","journal-title":"World J Emerg Surg"},{"key":"6760_CR33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.burns.2004.11.008","volume":"31","author":"FW Endorf","year":"2005","unstructured":"Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns. 2005;31:269\u201373.","journal-title":"Burns"},{"key":"6760_CR34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2015.08.054","volume":"73","author":"C Hua","year":"2015","unstructured":"Hua C, Sbidian E, Hemery F, Decousser JW, Bosc R, Amathieu R, et al. Prognostic factors in necrotizing soft-tissue infections (NSTI): a cohort study. J Am Acad Dermatol. 2015;73:1006-12.e8.","journal-title":"J Am Acad Dermatol"},{"key":"6760_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.amjsurg.2010.07.041","volume":"202","author":"LS Kao","year":"2011","unstructured":"Kao LS, Lew DF, Arab SN, Todd SR, Awad SS, Carrick MM, et al. Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study. Am J Surg. 2011;202:139\u201345.","journal-title":"Am J Surg"},{"key":"6760_CR36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00000658-199611000-00011","volume":"224","author":"D Elliott","year":"2006","unstructured":"Elliott D, Kufera JMR. Necrotizing soft tissue infections\u202f: risk factors for mortality and strategies for management. Ann Surg. 2006;224:672\u201383.","journal-title":"Ann Surg"},{"key":"6760_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archsurg.140.2.151","volume":"140","author":"DA Anaya","year":"2005","unstructured":"Anaya DA, McMahon K, Nathens AB, Sullivan SR, Foy H, Bulger E. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg. 2005;140:151\u20137; discussion 158.","journal-title":"Arch Surg"},{"key":"6760_CR38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.asjsur.2015.10.008","volume":"40","author":"P Kha","year":"2017","unstructured":"Kha P, Colot J, Gervolino S, Guerrier G. Necrotizing soft-tissue infections in New Caledonia: epidemiology, clinical presentation, microbiology, and prognostic factors. Asian J Surg. 2017;40:290\u20134.","journal-title":"Asian J Surg"},{"key":"6760_CR39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FEJ Harrell","year":"1996","unstructured":"Harrell FEJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"6760_CR40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373\u20139.","journal-title":"J Clin Epidemiol"},{"key":"6760_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0175130","volume":"12","author":"A Leligdowicz","year":"2017","unstructured":"Leligdowicz A, Conroy AL, Hawkes M, Zhong K, Lebovic G, Matthay MA, et al. Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection. PLoS ONE. 2017;12:1\u201314.","journal-title":"PLoS ONE"},{"key":"6760_CR42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00365540110080233","volume":"34","author":"G Kronborg","year":"2002","unstructured":"Kronborg G, \u00d8stergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis. 2002;34:323\u20136.","journal-title":"Scand J Infect Dis"},{"key":"6760_CR43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/resp.12924","volume":"22","author":"SMC Spoorenberg","year":"2017","unstructured":"Spoorenberg SMC, Vestjens SMT, Rijkers GT, Meek B, van Moorsel CHM, Grutters JC, et al. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology. 2017;22:542\u201350.","journal-title":"Respirology"},{"key":"6760_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/mcp.M111.013094","volume":"11","author":"B Maddens","year":"2012","unstructured":"Maddens B, Ghesqui\u00e8re B, Vanholder R, Demon D, Vanmassenhove J, Gevaert K, et al. Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury. Mol Cell Proteomics. 2012;11:1\u201313.","journal-title":"Mol Cell Proteomics"},{"key":"6760_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11090767","volume":"11","author":"TK Outinen","year":"2019","unstructured":"Outinen TK, Mantula P, Jaatinen P, H\u00e4m\u00e4l\u00e4inen M, Moilanen E, Vaheri A, et al. Glycoprotein YKL-40 is elevated and predicts disease severity in puumala hantavirus infection. Viruses. 2019;11:1\u201311.","journal-title":"Viruses"},{"key":"6760_CR46","doi-asserted-by":"publisher","first-page":"1411.e1","DOI":"10.1016\/j.cmi.2020.01.010","volume":"26","author":"AD Kjaergaard","year":"2020","unstructured":"Kjaergaard AD, Helby J, Johansen JS, Nordestgaard BG, Bojesen SE. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Clin Microbiol Infect. 2020;26:1411.e1-1411.e9. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.010.","journal-title":"Clin Microbiol Infect"},{"key":"6760_CR47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12935-019-0983-y","volume":"19","author":"B Bian","year":"2019","unstructured":"Bian B, Li L, Yang J, Liu Y, Xie G, Zheng Y, et al. Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies. Cancer Cell Int. 2019;19:259.","journal-title":"Cancer Cell Int"},{"key":"6760_CR48","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2005-07-2843","volume":"107","author":"J Kzhyshkowska","year":"2006","unstructured":"Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Schmuttermaier C, Krusell L, et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood. 2006;107:3221\u20138.","journal-title":"Blood"},{"key":"6760_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cyto.2011.03.014","volume":"55","author":"AR Nielsen","year":"2011","unstructured":"Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL-6, but not TNF-\u03b1, increases plasma YKL-40 in human subjects. Cytokine. 2011;55:152\u20135. https:\/\/doi.org\/10.1016\/j.cyto.2011.03.014.","journal-title":"Cytokine"},{"issue":"67","key":"6760_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109498","volume":"2020","author":"K H\u00fcbner","year":"2019","unstructured":"H\u00fcbner K, Karwelat D, Pietsch E, Beinborn I, Winterberg S, Bedenbender K, et al. NF-\u03baB-mediated inhibition of microRNA-149-5p regulates Chitinase-3-like 1 expression in human airway epithelial cells. Cell Signal. 2019;2020(67): 109498. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109498.","journal-title":"Cell Signal"},{"key":"6760_CR51","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1096\/fj.201902988RR","volume":"34","author":"D Karwelat","year":"2020","unstructured":"Karwelat D, Schmeck B, Ringel M, Benedikter BJ, H\u00fcbner K, Beinborn I, et al. Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection. FASEB J. 2020;34:16432\u201348.","journal-title":"FASEB J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:11:31Z","timestamp":1633896691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6760"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06760-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethical Committee of Capital Region (H-2-2014-071) and the Danish Data Protection Agency (no. 30-1282). Written informed consent was obtained from all patients or their legal surrogates. This study and all methods have been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1046"}}